Tag: FDA approvals

April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 24, 2018

Pharmaceutical Update: Q1 in Review

What happened in Q1 2018 for the pharma industry? Here's a look back at some of the quarter's biggest news...
April 1, 2018

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.
March 18, 2018

5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top

Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...
March 13, 2018

“China Will Become the Biggest Oncology Market in the World Over the Next 20 Years,” Says Chi-Med CEO Christian Hogg

Chi-Med, a China-based biopharmaceutical company, is making a name for itself within the oncology field at a global scale.
February 15, 2018

AMAG Pharmaceuticals Announces FDA Approval of Makena

AMAG Pharmaceuticals (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) approved the Makena® subcutaneous auto-injector drug-device combination...
February 13, 2018

Cancer Therapies to Reach $26.61 billion by 2025, Report Says

A new report by Grandview Research suggests that global novel drug delivery systems (NDDS) in cancer therapies will reach $26.61...